Cutimed - order your free sample pack!
Pack includes: product samples, quick guides to exudate management and AMS, the Cutimed Cube and other resources!
Cutimed Sorbact is suitable for early intervention and is designed with Sorbact Technology that prevent and treat wound infection by binding and inhibiting bacteria so antimicrobial resistance is not expected.1,2,3,6,12 Smart technology, packed into the tiniest details. And it's those tiny details that make a big impact.
About 40% of chronic wounds develop a wound infection⁴; let’s lower that number.
Want to know more about early intervention on wounds at risk of infection and treatment of infected wounds?
Products designed for effective infection management¹²
The Cutimed Sorbact range of dressings covers all stages of the wound healing process.
Cutimed® Siltec® Sorbact® - now with improved absorption - is a smart way to manage infection and exudate. This new bacteria and fungi binding foam dressing with Sorbact Technology is suitable for use on infected, low to moderate exuding wounds.
No release of active substances into the wound.⁵ Antimicrobial resistance is not expected.⁶
Use Cutimed Sorbact as an early intervention approach1,9
Early intervention supports the use of proactive infection prevention for hard-to-heal wounds with a high risk of infection during the contamination and colonisation phases by reducing the wound bioburden. Early intervention may prevent a wound infection from spreading and reduce the risk of systemic infection. It may also help avoid treating the wound with antibiotics - supporting Antimicrobial Stewardship (AMS) strategies.
Why choose Cutimed Sorbact right from the start?
- Suitable for early intervention on wounds at risk of infection.1,9,10
- Safe for the most delicate patients, from newborns to elderly.10,11,12
- Versatile, safe and easy to use.10,11,12
The value of safe and effective wound management
Suitable for early intervention1
- Inhibits growth of common wound pathogens incl MRSA6,13 and VRE13
- No limitations in treatment time12
Effective wound healing
- Effectively treats wound infection12,15
- Proven cell safety14
- No endotoxin release14
Safe & reliable
- Can be used across patient groups10,11,12*
- No known contraindications
- Non-cytotoxic14
Antimicrobial resistance is not expected
- No release of active substances6
- May reduce the need for antibiotics16
Find out more about Sorbact Technology
Learn more about how Cutimed Sorbact can help your patients
Effective in reducing bacterial burden
A study shows that Cutimed Sorbact is effective in reducing the bacterial burden7,8 in critically colonised or locally infected chronic leg ulcers.
Respond to the rise of antimicrobial resistance with Cutimed Sorbact
The whole world has woken up to the challenge of antimicrobial resistance (AMR). Without effective tools for prevention and adequate treatment of infections, the number of people for whom treatment is failing will increase.
Cutimed - order your free sample pack!
Pack includes: product samples, quick guides to exudate management and AMS, the Cutimed Cube and other resources!
Disclaimer
* Note precautions for Cutimed Sorbact Hydro/Sorbact Gel Compress in Instructions For Use.
References
- Stanirowski PJ et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.
- Magro M. Reducing surgical site infections post-caesarean section. International Journal of Women’s Health. 2023;15:1811-1819.
- Bua N et al. Dialkylcarbamoyl chloride dressings in the prevention of surgical site infections after nonimplant vascular surgery. Ann Vasc Surg. 2017;44:387-392.
- Simel DL & Rennie D eds. The rational clinical examination: Evidence-based clinical diagnosis. McGraw-Hill. 2009.
- Susilo YB et al. Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. J Wound Care. 2022;31:502-509.
- Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study.
- Ciliberti M et al. The effect of a bacteria- and fungi-binding mesh dressing on the bacterial load of pressure ulcers treated with negative pressure wound therapy: A pilot study. Wounds. 2016;28:408-420.
- Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-127.
- Corsi A et al. Is prevention of chronic traumatic ulcers possible? An observational study with use of DACC. Poster EWMA. May 23-25, 2012. Vienna, Austria.
- Ciprandi G et al. Meeting the challenges in pediatric wound care: Our 15-year experience with dialkylcarbamoyl chloride-coated dressing technology in acute and chronic wounds. Chronic Wound Care Management and Research. 2022;9:23-33.
- Meberg A & Schoyen R. Hydrophobic material in routine umbilical cord care and prevention of infections in newborn infants. Scand J Infect Dis. 1990;22:729-733
- Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.
- Ronner AC, et al. Adhesion of meticillin-resistant Staphylococcus aureus to DACC-coated dressings. J Wound Care. 2014 23(10):484, 486-488.
- Morgner B et al. Effect of a DACC-coated dressing on keratinocytes and fibroblasts in wound healing using an in vitro scratch model. J Mater Sci Mater Med. 2022;33(2):22.
- Rippon M, et al. Experimental and clinical evidence for DACC-coated dressings: an update. J Wound Care. 2023 Aug 1;32(Sup8a):S13-S22.
- Stanirowski PJ et al. Dialkylcarbamoyl chloride-impregnated dressing for the prevention of surgical site infection in women undergoing cesarean section: a pilot study. Arch Med Sci. 2016;12(5):1036-1042.